Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Neos Therapeutics

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 5Neos Therapeutics, LP

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    01

    FDA Audited

    USA
    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-02-26

    Neos Therapeutics

    City : Grand Prairie

    State : TX

    Country/Area : US

    Zip : 75050-6424

    District : DAL

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2010-02-26

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    02

    FDA Audited

    USA
    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-05-27

    Neos Therapeutics

    City : Grand Prairie

    State : TX

    Country/Area : US

    Zip : 75050-6424

    District : DAL

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-05-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    03

    FDA Audited

    USA
    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-05-27

    Neos Therapeutics

    City : Grand Prairie

    State : TX

    Country/Area : US

    Zip : 75050-6424

    District : DAL

    Center : CFSAN

    Project Area : Food Composition, Standards, Lab...

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2011-05-27

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    04

    FDA Audited

    USA
    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-06-04

    Neos Therapeutics

    City : Grand Prairie

    State : TX

    Country/Area : US

    Zip : 75050-6424

    District : DAL

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2015-06-04

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    05

    FDA Audited

    USA
    Pharma, Lab & Chemical Expo
    Not Confirmed
    arrow

    FDA Audited

    USA
    arrow
    Pharma, Lab & Chemical Expo
    Not Confirmed

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-07-25

    Neos Therapeutics

    City : Grand Prairie

    State : TX

    Country/Area : US

    Zip : 75050-6425

    District : DAL

    Center : CDER

    Project Area : Drug Quality Assurance

    District Decision : Voluntary Action Indicated

    Inspection End Date : 2017-07-25

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow